维普中文期刊产品整合服务
62篇 您的检索式:作者名="BASTIDA S"
    题名 作者 年代 出处 被引量
1Small intestinal bacterial overgrowth in inactive Crohn's disease:Influence of thiopurine and biological treatment显示文摘AIM:To investigate the influence of thiopurines and biological drugs on the presence of small intestinal bacterial overgrowth(SIBO) in patients with inactive Crohn's disease(CD).METHODS:This was a prospective study in patients with CD in remission and without corticosteroid treatment,included consecutively from 2004 to 2010.SIBO was investigated using the hydrogen glucose breath test.RESULTS:One hundred and seven patients with CD in remission were included.Almost 58%of patients used maintenance immunosuppressant therapy and 19.6%used biological therapy.The prevalence of SIBO was16.8%.No association was observed between SIBO and the use of thiopurine Immunosuppressant(12/62patients),administration of biological drugs(2/21 patients),or with double treatment with an anti-tumor necrosis factor drugs plus thiopurine(1/13 patients).Half of the patients had symptoms that were suggestive of SIBO,though meteorism was the only symptom that was significantly associated with the presence of SIBO on univariate analysis(P<0.05).Multivariate analysis revealed that the presence of meteorism and a fistulizing pattern were associated with the presence of SIBO(P<0.05).CONCLUSION:Immunosuppressants and/or biological drugs do not induce SIBO in inactive CD.Fistulizing disease pattern and meteorism are associated with SIBO.Cristina Sánchez-Montes Vicente Ortiz Guillermo Bastida Ester Rodríguez María Yago Belén Beltrán Mariam Aguas Marisa Iborra Vicente Garrigues Julio Ponce Pilar Nos 2014World Journal of Gastroenterology2014,20,38:4
2Adalimumab in prevention of postoperative recurrence of Crohn's disease in high-risk patients显示文摘AIM:To evaluate the effectiveness of adalimumab in preventing recurrence after intestinal resection for Crohn's disease in high-risk patients.METHODS:A multicenter,prospective,observational study was conducted from June 2009 until June 2010.We consecutively included high-risk Crohn's disease patients who had undergone an ileal/ileocolonic resection.High-risk patients were defined as two or more criteria:smokers,penetrating pattern,one or more previous surgical resections or prior extensive resection.Subcutaneous adalimumab was administered 2 wk(± 5 d) after surgery at a dose of 40 mg eow,with an initial induction dose of 160/80 mg at weeks 0 and 2.Demographic data,previous and concomitant treatments(antibiotics,5-aminosalicylates,corticosteroids,immunomodulators or biologic therapies),smoking status at the time of diagnosis and after the index operation and number of previous resections(type and reason for surgery) were all recorded.Biological status was assessed with C-reactive protein,erythrocyte sedimentation rate and fecal calprotectin.One year(± 3 mo) after surgery,an ileocolonoscopy and/or magnetic resonance enterography was performed.Endoscopic recurrence was defined as Rutgeerts score ≥ i2.Morphological recurrence was based on magnetic resonance(MR) score ≥ MR1.RESULTS:Twenty-nine patients(55.2% males,48.3% smokers at diagnosis and 13.8% after the index operation),mean age 42.3 years and mean duration of the disease 13.8 years were included in the study.A mean of 1.76(range:1-4) resections previous to adalimumab administration and in 37.9% was considered extensive resection.51.7% had previously received infliximab.Immunomodulators were given concomitantly to 17.2% of patients.Four of the 29(13.7%) developed clinical recurrence,6/29(20.7%) endoscopic recurrence and 7/19(36.8%) morphological recurrence after 1-year.All patients with clinical recurrence showed endoscopic and morphological recurrence.A high degree of concordance was found between clinical-endoscopic recurrence(k = 0.76,P < 0.001) and clinical-morphological recurrence(k = 0.63,P = 0.003).Correlation between endoscopic and radiological findings was good(comparing the 5-point Rutgeerts score with the 4-point MR score,a score of i4 was classified as MR3,i3 as MR2,and i2-i1 as MR1)(P < 0.001,r s = 0.825).During follow-up,five(17.2%) patients needed adalimumab dose intensification(40 mg/wk);Mean time to intensification after the introduction of adalimumab treatment was 8 mo(range:5 to 11 mo).In three cases(10.3%),a biological change was needed due to a worsening of the disease after the dose intensification to 40 mg/wk.One patient suffered an adverse event.CONCLUSION:Adalimumab seems to be effective and safe in preventing postoperative recurrence in a selected group of patients who had undergone an intestinal resection for their CD.Mariam Aguas Guillermo Bastida Elena Cerrillo Belén Beltrán Marisa Iborra Cristina Sánchez-Montes Fernando Muoz Jesús Barrio Sabino Riestra Pilar Nos 2012World Journal of Gastroenterology2012,18,32:3
3The Protective Action of Two Vapor-Phase Inhibitors on the Corrosion of Mild Steel显示文摘Bastidas J M Mora E M Feliu S 1990Werkstoffe Korrosion1990,41,9:1
4Study of the electrochemical noise generated by the mild steel/zinc - rich paint/NaCl solution system 显示文摘Bastidas J M Feliu S Jr Morcillo M 1990Progress in Organic Coatings1990,18,3:1
5Power-assisted suction lipectomy of fasciocutaneous flaps in the extremities显示文摘Reuben CM Bastidas N Sharma S 2010Ann Plast Surg2010,65,1:1
6Male and female cord blood lipoprotein profile differences throughout the term-period显示文摘Bastida S Sanchez-Muniz FJ Cuesta C 1997J Perinat Med1997,25,:1
7Fasting status and thermally oxidized sunflower oil ingestion affect the in-testinal antioxidant enzyme activity and gene expression of male Wistar rats显示文摘Olivero David R Bastida S Schultz A 0,,04:1
8Parameter Estimation of A Land Surface Scheme Using Multicriteria Methods显示文摘Gupta H V Bastidas L A Sorooshian S 1999Journal of Geophysical Research1999,104,16:1
9A contribution to the study on electropolishing of mild steel and aluminium using alternating current 显示文摘LABARGA J E BASTIDAS J M FELIU S 1991Electroehimica Acta1991,36,1:1
10Effects of APOA5 S19W polymorphism on growth,insulin sensitivity and li-poproteins in normoweight neonates显示文摘Gesteiro E Bastida S Vázquez-Velasco M 0,,12:1
11Synthesis of the aminocyclopentitol moieties of the hopanoids of Zy- momonas mobilis and Anacystis Montana 显示文摘Chiara J L de Gracia I S Bastida A 2003Chem Comm2003,15,:1
12Composition and antioxidant capacity of low-salt meat emulsion model systems containing edible seaweeds显示文摘Lopez-Lopez I Bastida S Ruiz-Capillas C 2009Meat Science2009,83,:1
13Small Supplements of N-3 Fatty Acids Change Serum Low Density Lipoprotein Composition by Decreasing Phospholipid and Apolipoprotein B Concentrations in Young Adult Women 显示文摘Sanchez-Muniz F J Bastida S Viejo J M 1999Eur J Nutr1999,38,:1
14The effect of consuming meat enriched in walnut paste on platelet aggregation and thrombogenesis varies in volunteers with different apolipoprotein A4 genotype显示文摘Canales A Benedi J Bastida S 2010Nutr Hosp2010,25,5:1
15Cyclic fatty acid monomer formation in domestic frying of frozen foods in sunflower oil and high oleic acid sunflower oil without oil replenishment 显示文摘Romero A Bastida S Sanchez- Muniz F J 2006Food and chemical toxicology2006,44,10:1
16Anti-human im- munodeficiency virus type 1 (HIV-1)activity of lectins from Narcissus species 显示文摘Lopez S Armand-Ugon M Bastida J 2003Planta Medica2003,69,2:1
17Galanthamine production in 'shoot-clump' cultures of Narcissus confusus in liquid-shake medium显示文摘Bergonon S Codina C Bastida J 1996Plant Cell Tissue and Organ Culture1996,45,3:1
18Biochar influences the microbial community structure during manure composting with agricultural wastes显示文摘Keiji Jindo Miguel A. Sánchez-Monedero Teresa Hernández Carlos García Toru Furukawa Kazuhiro Matsumoto Tomonori Sonoki Felipe Bastida 2011Science of the Total Environment2011,,:1
19Mechanism of cathodic protection of zinc-rich paints by electrochemical impedance spectroscopy--Ⅰ: Galvanic stage 显示文摘FELIU S BARAJAS R BASTIDAS J M 1989Journal of Coatings Technology1989,61,775:1
20Anti-human immunodeficiency virus type 1(HIV-1)activity of lectins from Narcissus species显示文摘Lopez S Armand-Ugon M Bastida J 2003Planta Med2003,69,2:1
返回顶部 每页显示:
共4页 首页 上一页 第1页 下一页 末页 /4 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费